Evidence map›Paper›PMID 23822148›Full record

ArticleBMC molecular biology2013

Tip110 interacts with YB-1 and regulates each other's function.

Khalid Amine Timani, Ying Liu, Johnny J He

Open access · hybridAbstract read
In one paragraph

Article in BMC molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. 7SL RNA in vertebrate red blood cells.RNA (New York, N.Y.) · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Khalid Amine TimaniUniversity of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Ying Liu
Johnny J He
University of North Texas Health Science Center · USUniversity of North Texas · US

Funding

GFAP as a novel HIV/neuroAIDS biomarkerR01MH092673 · NIMH · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI HE, JOHNNY J · 2010 to 2014
$2.4M
NIMH NIH HHS R01 MH092673
6 · The paper itself

Abstract

backgroundTip110 plays important roles in tumor immunobiology, pre-mRNA splicing, expression regulation of viral and host genes, and possibly protein turnover. It is clear that our understanding of Tip110 biological function remains incomplete.

resultsHerein, we employed an immunoaffinity-based enrichment approach combined with protein mass spectrometry and attempted to identify Tip110-interacting cellular proteins. A total of 13 major proteins were identified to be complexed with Tip110. Among them was Y-box binding protein 1 (YB-1). The interaction of Tip110 with YB-1 was further dissected and confirmed to be specific and involve the N-terminal of both Tip110 and YB-1 proteins. A HIV-1 LTR promoter-driven reporter gene assay and a CD44 minigene in vivo splicing assay were chosen to evaluate the functional relevance of the Tip110/YB-1 interaction. We showed that YB-1 potentiates the Tip110/Tat-mediated transactivation of the HIV-1 LTR promoter while Tip110 promotes the inclusion of the exon 5 in CD44 minigene alternative splicing.

conclusionsTip110 and YB-1 interact to form a complex and mutually regulate each other's biological functions.

Indexed as

Amino Acid MotifsAntigens, NeoplasmCell LineHIV Long Terminal RepeatHumansProtein BindingRNA-Binding Proteinstat Gene Products, Human Immunodeficiency VirusTranscriptional ActivationY-Box-Binding Protein 1Antigens, NeoplasmRNA-Binding ProteinsSART3 protein, humantat Gene Products, Human Immunodeficiency VirusY-Box-Binding Protein 1YBX1 protein, human

Identifiers

PMID23822148
PMCPMC3716619
OpenAlexW2025717071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.